Cyclopharm Ltd has released a press release.
40 Patient Milestone Achieved For Technegas USFDA Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cyclopharm
- CYC CEO Presentation 2017 Australian Microcap Conference
- Technegas USFDA Clinical Trial - Patient Enrolment Underway
- Cyclopharm acquires European distribution business
- Advancing Molecular Imaging in NSW
- Dividend/Distribution - CYC
Later from Cyclopharm
- Cyclopharm Acquires Scandinavian Distribution Business
- Better Defining Airways Disease with Technegas
- CYC 2018 AGM Presentation
- Cyclopharm 2018 First Half Preliminary Headline Update
- Positive USFDA Meeting - Technegas sales expected in 2019
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm